JAMA : the journal of the American Medical Association
-
Supplemental oxygen is ubiquitously used in patients with COVID-19 and severe hypoxemia, but a lower dose may be beneficial. ⋯ In adult ICU patients with COVID-19 and severe hypoxemia, targeting a Pao2 of 60 mm Hg resulted in more days alive without life support in 90 days than targeting a Pao2 of 90 mm Hg.
-
Editorial Comment
Your Mileage May Vary: Toward Personalized Oxygen Supplementation.